Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription- polymerase chain reaction assay and protein analysis

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4233-4236

  Peters, Uwe R ^a   Tschan, Mario P ^b   Kreuzer, Karl A ^a   Baskaynak, Gökben ^a   Lass, Ulrich ^a   Tobler, Andreas ^b   Fey, Martin F ^b   Schmidt, Christian A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P73; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ARTICLE; BLAST CELL CRISIS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ALLELES; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033199166     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
2. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P., and Fenaux, P. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84: 3148-3157, 1994.
3. Neubauer, A., He, M., Schmidt, C. A., Huhn, D., and Liu, E. T. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Leukemia (Baltimore), 7: 593-600, 1993.
4. Fenaux, P., Preudhomme, C., Quiquandon, I., Jonveaux, P., Lai, J. L., Vanrumbeke, M., Loucheux-Lefebvre, M. H., Bauters, F., Berger, R., and Kerckaert, J. P. Mutations of the P53 gene in acute myeloid leukaemia. Br. J. Haematol., 80: 178-183, 1992.
5. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819, 1997.
6. De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M., and Melino, G. Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med., 188: 1763-1768, 1998.
7. Mai, M., Qian, C., Yokomizo, A., Tindall, D. J., Bostwick, D., Polychronakos, C., Smith, D. I., and Liu, W. Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene, 17: 1739-1741, 1998.
8. Jost, C. A., Marin, M. C., and Kaelin, W. G., Jr. p73 is a human p53-related protein that can induce apoptosis. Nature (Lond.), 389: 191-194, 1997.
9. Zhu, J., Jiang, J., Zhou, W., and Chen, X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res., 58: 5061-5065, 1998.
10. Marin, M. C., Jost, C. A., Irwin, M. S., DeCaprio, J. A., Caput, D., and Kaelin, W. G., Jr. Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol., 18: 6316-6324, 1998.
11. Higashino, F., Pipas, J. M., and Shenk, T. Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proc. Natl. Acad. Sci. USA, 95: 15683-15687, 1998.
12. Mai, M., Yokomizo, A., Qian, C., Yang, P., Tindall, D. J., Smith, D. I., and Liu, W. Activation of p73 silent allele in lung cancer. Cancer Res., 58: 2347-2349, 1998.
13. Takahashi, H., Ichimiya, S., Nimura, Y., Watanabe, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S., and Nakagawara, A. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res., 58: 2076-2077, 1998.
14. Kawano, S., Miller, C. W., Gombart, A. F., Bartram, C. R., Matsuo, Y., Asou, H., Sakashita, A., Said, J., Tatsumi, E., and Koeffler, H. P. Loss of p73 gene expression, in leukemias/lymphomas due to hypermethylation. Blood, 94: 1113-1120, 1999.
15. Stirewalt, D. L., Clurman, B., Appelbaum, F. R., Willman, C. L., and Radich, J. P. p73 mutations and expression in adult de novo acute myelogenous leukemia. Leukemia, 13: 985-990, 1999.
16. Corn, P., van Noesel, M., Baylin, S., Herman, J., and Kuerbitz, S. Hypermethylation of the p73 5′CpG island in primary acute lymphocytic leukemias and Burkitt's lymphomas. Proc. Am. Assoc. Cancer Res., 40: 546, 1999.
17. Kreuzer, K. A., Lass, U., Landt, O., Nitsche, A., Laser, J., Ellerbrok, H., Pauli, G., Huhn, D., and Schmidt, C. A. Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of β-actin transcripts as quantitative reference. Clin. Chem., 45: 297-300, 1999.
18. Peters, U. R., Hasse, U., Oppliger, E., Tschan, M., Ong, S. T., Rassool, F. V., Borisch, B., Tobler, A., and Fey, M. F. Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia. Oncogene, 18: 79-85, 1999.
19. Mon, N., Morosetti, R., Spira, S., Lee, S., Ben-Yehuda, D., Schiller, G., Landolfi, R., Mizoguchi, H., and Koeffler, H. P. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood, 92: 3405-3409, 1998.
20. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., and Takahashi, T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58: 1380-1383, 1998.
21. Di Como, C. J., Gaiddon, C., and Prives, C. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol., 19: 1438-1449, 1999.